Day: May 22, 2020

SECAUCUS, N.J., May 22, 2020 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) today announced that it has agreed to settle the shareholder derivative litigation Meldon v. Freshpet, Inc. et al., which had been pending in the United States District Court for the District of New Jersey against the Company, as a nominal defendant, and certain of the Company’s current and former directors and executive officers.  The settlement is subject to Court approval.  The Court has granted preliminary approval, pursuant to which the Company is issuing this release and making disclosure of the settlement to its shareholders in the attached Notice to Current Freshpet Stockholders (“Notice”).  In connection with the proposed settlement, all of the defendants deny any liability and the Company has agreed to continue certain corporate...

TORONTO, May 22, 2020 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV; NASDAQ: FSV) (“FirstService”) is pleased to report that today it completed the sale, on a private placement basis, of a total of 1,797,359 common shares (the “Common Shares”) of FirstService, at a price of US$83.46 per share, to Durable Capital Partners LP (“Durable Capital”), for proceeds of approximately US$150 million (the “Private Placement”). In connection with the Private Placement, FirstService granted customary registration rights to Durable Capital for the future resale of the Common Shares purchased in the Private Placement.FirstService intends to use the proceeds of the Private Placement to repay a portion of its existing indebtedness under its revolving credit facility, to finance potential future acquisitions, and to fund working capital and...

Scheduled to Reconvene June 19, 2020Company Strongly Encourages Stockholders to VoteEDEN PRAIRIE, Minn., May 22, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) (“CHF Solutions”) today announced that its 2020 Annual Meeting of Stockholders held on May 20, 2020 convened and then adjourned until June 19, 2020 2:00 p.m. US Central Time at https://web.lumiagm.com/257409059 to solicit additional proxies for Proposal 3, granting the Board of Directors the discretion to implement a reverse stock split (“Proposal 3”).The Board of Directors believes approval of Proposal 3 is in the best interests of CHF Solutions and its stockholders because a reverse stock split may be necessary to maintain the listing of CHF Solutions’ common stock on the NASDAQ Capital Market (“Nasdaq”). A delisting of the common stock from Nasdaq could significantly...

HIGH POINT, N.C., May 22, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that it will host its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) as a virtual-only meeting that will be held via live audio webcast due to the public health and safety concerns related to the COVID-19 pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees, and others.The previously announced date and time of the Annual Meeting, Thursday, June 11, 2020 at 9:00 a.m. Eastern Daylight Time, as disclosed in the previously distributed Notice of the Annual Meeting and Definitive Proxy Statement (the “Notice and Proxy Statement”), has not changed. Stockholders will not be able to attend the Annual Meeting...

VANCOUVER, British Columbia, May 22, 2020 (GLOBE NEWSWIRE) — Auralite Investments Inc. (TSX Venture: AAAA) (the “Company” or “Auralite”), is pleased to provide the following update in regards to recent activity.Recent TransactionsAuralite has closed a $1,000,000 investment into Gold Lion Resources Inc. (“Gold Lion”). Pursuant to the investment, Auralite has acquired an aggregate of 2,000,000 common shares of Gold Lion (“Gold Lion Shares”) and 2,000,000 common share purchase warrants exercisable for an additional 2,000,000 Gold Lion Shares at a price of $0.75 for a period of 24 months from issuance.Auralite has disposed of its interest in Singapore-based EVVO Labs Pte. Ltd. back to EVVO, in consideration for a $250,000 (Singapore dollars) secured promissory note (the “Secured Note”).  The Secured...

SAN JOSE, Calif., May 22, 2020 (GLOBE NEWSWIRE) — Synaptics Incorporated (NASDAQ: SYNA), the leading developer of human interface solutions, today announced the appointment of Susan Hardman to its Board of Directors, effective May 22, 2020. Ms. Hardman will join the Board’s Compensation Committee.Ms. Hardman enjoyed a distinguished career in senior management roles in the semiconductor industry. She held several executive positions at Intersil Corporation, including senior vice president of the Automotive and Specialty Products Group, senior vice president of the Analog and Mixed Signal Product Group, and vice president of Corporate Marketing. Ms. Hardman joined Intersil from Exar where she was vice president and general manager of the Interface Products Division, as well as vice president of Corporate Marketing. She also held roles...

MELBOURNE, Fla., May 22, 2020 (GLOBE NEWSWIRE) — The Goldfield Corporation (NYSE American: GV) released the comments made earlier today by Mr. John H. Sottile, President, Chief Executive Officer and Chairman of the Board, at The Goldfield Corporation’s annual meeting of stockholders. Goldfield is headquartered in Melbourne, Florida, and through its subsidiaries, Power Corporation of America, C and C Power Line, Inc., Southeast Power Corporation and Precision Foundations, Inc., is a leading provider of electrical construction services for the utility industry and industrial customers, with operations primarily in the Southeast, mid-Atlantic and Texas-Southwest regions of the United States. To a lesser extent, Goldfield is also engaged in real estate operations focused on the development of residential properties on the east coast...

MONTREAL, May 22, 2020 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (“Harfang”) (TSX-V: HAR) announces the grant of 300,000 stock options to directors, officers and employees and 37,500 stock options to consultants. These stock options are granted in accordance with the terms of the stock option plan of Harfang. All options vest on their date of grant and each option entitles the holder thereof to purchase one (1) common share of Harfang at a price of $0.25 per common share for a period of ten (10) years from May 22, 2020.Harfang also announces that, subject to required approvals from regulatory authorities, it will extend until July 12, 2022 the expiry date of 1,282,500 common share purchase warrants issued in connection with a private placement closed on July 12, 2018, under which Harfang distributed 2,565,000 units at a price...

MONTREAL, 22 mai 2020 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (« Harfang ») (TSX.V: HAR) annonce l’octroi de 300 000 options d’achat d’actions à ses administrateurs, ses dirigeants et employés et 37 500 options d’achat d’actions à des consultants. Ces options sont octroyées conformément aux modalités du régime d’options d’achat d’actions d’Harfang. Toutes les options sont acquises à la date de leur octroi et chaque option confère à son porteur le droit d’acquérir une (1) action ordinaire d’Harfang au prix de 0,25 $ par action ordinaire pour une période de dix (10) ans à compter du 22 mai 2020.Harfang annonce également que sous réserve des approbations requises des autorités de réglementation, elle prolongera jusqu’au 12 juillet 2022 la date d’expiration de 1 282 500 bons de souscription ayant été émis à l’occasion d’un placement...

Company Announcement – No. 28 / 2020Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemiaThe dasiglucagon HypoPal® rescue pen New Drug Application represents a major milestone in Zealand Pharma’s efforts to bring life changing therapies to people with diabetes PDUFA target action date scheduled for March 27, 2021Copenhagen, May 22, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a biotechnology company changing lives with innovative peptide-based medicines, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) for  the dasiglucagon HypoPal® Rescue Pen for the treatment of hypoglycemia in people with diabetes. Under the Prescription Drug User Fee Act (PDUFA), the FDA has...